Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
Tóm tắt
The NF-κB/REL-family of transcription factors plays a central role in coordinating the expression of a wide variety of genes controlling immune responses including autoimmunity of the central nervous system (CNS). The inactive form of NF-κB consists of a heterodimer which is complexed with its inhibitor, IκB. Conditional knockout-mice for IκBα in myeloid cells (lysMCreIκBαfl/fl) have been generated and are characterized by a constitutive activation of NF-κB proteins allowing the study of this transcription factor in myelin-oligodendrocyte-glycoprotein induced experimental autoimmune encephalomyelitis (MOG-EAE), a well established experimental model for autoimmune demyelination of the CNS. In comparison to controls, lysMCreIκBαfl/fl mice developed a more severe clinical course of EAE. Upon histological analysis on day 15 p.i., there was an over two fold increased infiltration of T-cells and macrophages/microglia. In addition, lysMCreIκBαfl/fl mice displayed an increased expression of the NF-κB dependent factor inducible nitric oxide synthase in inflamed lesions. These changes in the CNS are associated with increased numbers of CD11b positive splenocytes and a higher expression of Ly6c on monocytes in the periphery. Well in accordance with these changes in the myeloid cell compartment, there was an increased production of the monocyte cytokines interleukin(IL)-12 p70, IL-6 and IL-1beta in splenocytes. In contrast, production of the T-cell associated cytokines interferon gamma (IFN-gamma) and IL-17 was not influenced. In summary, myeloid cell derived NF-κB plays a crucial role in autoimmune inflammation of the CNS and drives a pathogenic role of monocytes and macrophages independently from T-cells.
Tài liệu tham khảo
Li Q, Verma IM: NF-κB regulation in the immune system. Nature Rev Immunol 2002, 2:725–734.
Ghosh S, Karin M: Missing pieces in the NF-κB puzzle. Cell 2002, 109:81–96.
Hayden MS, Ghosh S: Signaling to NF-κB. Genes Dev 2004, 18:2195–2224.
Li ZW, Rickert RC, Karin M: Genetic dissection of antigen receptor induced NF-κB activation. Mol Immunol 2004, 41:701–714.
Pahl H: Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999, 18:6853–6866.
Baeuerle PA, Henkel T: Function and activation of NFκB in the immune system. Annu Rev Immunol 1994, 12:141–179.
Grilli M, Jason JS, Leonardo MJ: NF-κB and rel-participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993, 143:1–62.
Bours S, Franzoso G, Brown K, Park S, Azarenke V, Tomita YM, Kelly K, Siebenlist U: Lymphocyte activation and the family of NF-κB transcription factor complexes. Curr Top Microbiol Immunol 1992, 182:411–420.
Müller JM, Ziegler-Heitbroc JHW, Beauerle PA: Nuclear factor κB, a mediator of lipopolysaccharide effects. Immunbiol 1993, 187:233–256.
Geller DA, Nussler AK, Di Silvio RL, Lowenstein CJ, Shapiro RA, Wang SC, Simmons RL, Billiar TR: Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993, 90:522–526.
Yamamoto K, Arakawa T, Ueda N, Yamamoto S: Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 1995, 270:31315–31320.
Rupec RA, Jundt F, Rebholz B, Eckelt B, Weindl G, Herzinger T, Flaig MJ, Moosmann S, Plewig G, Dörken B, Förster I, Huss R, Pfeffer K: Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa B alpha. Immunity 2005,22(4):479–91.
Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, Giess R: CNTF is a major protective factor in demyelinating CND disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 2002, 8:620–624.
Mews I, Bergmann M, Bunkowski S, Gullotta F, Brück W: Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler 1998,4(2):55–62.
Kaltschmidt B, Kaltschmidt C: NF-kappaB in the nervous system. Cold Spring Harb Perspect Biol 2009,1(3):a001271.
Tak PP, Firestein GS: NF-κB: a key role in inflammatory diseases. J Clin Invest 2001, 107:7–11.
Hilliard BA, Samoilova EB, Liu TS, Rostami A, Chen Y: Experimental autoimmune encephalomyelitis in NF-κB-deficient mice: roles of NF-κB in the activation and differentiation of autoreactive T cells. J Immunol 1999, 163:2937–2943.
Hilliard BA, Mason N, Xu L, Sun J, Lamhamedi-Cherradi SE, Liou HC, Hunter C, Chen YH: Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J Clin Invest 2002, 110:843–850.
Dasgupta S, Jana M, Zhou Y, Fung YK, Ghosh S, Pahan K: Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis. J Immunol 2004,15;173(2):1344–1354.
Greve B, Weissert R, Hamdi N, Bettelli E, Sobel RA, Coyle A, Kuchroo VK, Rajewsky K, Schmidt-Supprian M: I kappa B kinase 2/beta deficiency controls expansion of autoreactive T cells and suppresses experimental autoimmune encephalomyelitis. J Immunol 2007,1;179(1):179–85.
Wooten MW: Function for NF-κB in neuronal survival: regulation by atypical protein kinase. C J Neurosci Res 1999, 58:607.
Mattson MP, Culmsee C, Yu Z, Camandola S: Roles of NF-κB in neuronal survival and plasticity. J Neurochem 2000, 74:443.
Martin R, McFarland HF, McFarlin DE: Immunological aspects of demyelinating diseases. Annu Re Immunol 1992, 10:153.
Owens R, Sriram S: The immunology of MS and of its animal model, EAE. Neurol Clin 1995, 13:51.
Huitinga I, van Rooijen N, de Groot CJA, Uitdehaag BM, Dijkstra CD: Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990, 172:1025–1033.
Bauer J, Huitinga I, Zhao W, Lassmann H, Hickey WF, Dijkstra CD: The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia 1995,15(4):437–446.
Miller SD, McMahon EJ, Schreiner B, Bailey SL: Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 2007, 1103:179–191.
Collart MA, Baeuerle P, Vassalli P: Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 1990,10(4):1498–1506.
Liefner M, Siebert H, Sachse T, Michel U, Kollias G, Brück W: The role of TNF-alpha during Wallerian degeneration. J Neuroimmunol 2000,108(1–2):97–103.
Probert L, Eugster HP, Akassoglou K, Bauer J, Frei K, Lassmann H, Fontana A: TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 2000, 123:2005–2019.
Louis JC, Magal E, Takayama S, Varon S: CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 1993,259(5095):689–692.
Li S, Vana AC, Ribeiro R, Zhang Y: Distinct role of nitric oxide and peroxynitrite in mediating oligodendrocyte toxicity in culture and in experimental autoimmune encephalomyelitis. Neuroscience 2011, 184:107–119.
Okuda Y, Nakatsuji Y, Fujimura H, Esumi H, Ogura T, Yanagihara T, Sakoda S: Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J Neuroimmunol 1995,62(1):103–112.
Nikic I, Merkler D, Sorbara C, Birnkoetter M, Kreutzfeldt M, Bareyre FM, Brück W, Bishop D, Misgeld T, Kerschensteiner M: A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 2011,17(4):495–499.
Schreck R, Meier B, Männel DN, Dröge W, Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992,175(5):1181–1194.
Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, Wolter K, Piesche M, Schroers R, Weiss E, Kirschning CJ, Rochford CD, Brück W, Becher B: Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 2006,116(2):456–64.
Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H: TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 2007,4(4):675–689.
Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, Raasch J, Merkler D, Detje C, Gutcher I, Mages J, Lang R, Martin R, Gold R, Becher B, Brück W, Kalinke U: Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008, 28:675–686.